Clinical Trial Update: To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of converting liver transplant patients with hepatitis B to tenofovir alafenamide (TAF), including tho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hepatitis B

Drugs mentioned

• Vemlidy (tenofovir alafenamide)

Snippet

Sponsor: Jongman Kim | Conditions: Hepatitis B Virus, Liver Transplant | Phase 2 | Status: NOT_YET_RECRUITING